CClinicalTrials.gg
CompletedNCT00013741Updated May 24, 2012

The MI-HEART Project

An interventional study of Tailored Education Messages in Myocardial Infarction and Coronary Disease, sponsored by National Library of Medicine (NLM). Completed at 1 site in United States. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2012-05-24.

Sponsored by National Library of Medicine (NLM) · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Randomized
Ages
30 Years and older
Sex
All
01

Study summary

The purpose of the study is to examine ways in which a clinical information system can help patients better recognize the signs and symptoms of an acute myocardial infarction (heart attack) and to take actions to decrease morbidity and mortality that may be related to delay in seeking treatment. The software-based intervention will use the best scientific evidence to create tailored strategies using a patient's specific health data. This approach is based on well-established cognitive and behavioral educational models.

02

Conditions studied

  • Myocardial Infarction
  • Coronary Disease

Keywords

  • Acute Myocardial Infarction
  • Diabetes Mellitus
  • Renal Dialysis
  • Heart Attack
  • Coronary Heart Disease
03

In context

Myocardial Infarction

2,744 studies on the registry are indexed under Myocardial Infarction; 418 are open to participants now.

This study's enrollment of 55 is below the median of 148 across 1,595 interventional studies indexed under Myocardial Infarction.

Browse Myocardial Infarction studies →

Lead sponsor

National Library of Medicine (NLM) is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients at high-risk for an acute myocardial infarction, including any 2 of these risk factors: males age > 45; females age >55; family history of premature coronary heart disease (CHD); current cigarette smoker; hypertension; or elevated total cholesterol with low HDL and/or high LDL.

OR have:

  • Active angina (chest pain due to coronary heart disease)
  • History of coronary heart disease according to the treating physician
  • Past history of myocardial infarction documented by electrocardiogram or arteriography
  • Diabetes Mellitus
  • Renal dialysis

Exclusion criteria

Exclusion Criteria

  • Hospitalization within previous 4 weeks
  • Persons living in a home with previously enrolled patients
  • Patients disoriented to person, place, or time at onset of study
05

Study design

Phase
Not applicable
Allocation
Randomized
Masking
Double
Enrollment
55 participants

Interventions

  • BehavioralTailored Education Messages
06

Study locations

1 site
  • Columbia University, Department of Medical Informatics
    New York, New York, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 24, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00013741
Lead sponsor
National Library of Medicine (NLM)
First posted
Mar 30, 2001
Last update
May 24, 2012

Study contacts

James J. Cimino, M.D.
principal investigator · Columbia University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2003. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion